In connection with entering into the Series D Preferred Stock Purchase Agreement in 2025, the Company issued an aggregate amount of warrants to purchase 4,056,164 shares of the Company’s common stock, each with an exercise price of $0.10 per share (the “Common Warrants”). The Common Warrants were exercisable at any time by the holder and have a seven-year contractual term from their respective dates of issuance. Upon completion of the IPO, the outstanding Common Warrants were automatically net exercised pursuant to their terms and became shares of the Company’s common stock, effective immediately prior to the consummation of the IPO. The Company determined that the Common Warrants were equity-classified, and recorded the amounts allocated to the Common Warrants within additional paid‑in capital on the condensed consolidated balance sheets.

During the nine months ended September 30, 2026, 2,051 Common Warrants were exercised, resulting in the issuance of 2,051 shares of common stock and aggregate proceeds of a de minimis amount. The Company’s outstanding Common Warrants were automatically exercised on a net exercise basis into 3,287,352 shares of common stock immediately prior to the closing of the IPO. As of September 30, 2026, no Common Warrants remain issued and outstanding.